Paul J. Rutgeerts

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications

Author Correction: A20 controls intestinal homeostasis through cell-specific activities.

Author Correction: A20 controls intestinal homeostasis through cell-specific activities.

Journal: Nature communications
Published: March 31, 2025

Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease.

Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 16, 2019

Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.

Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.

Journal: Inflammatory bowel diseases
Published: August 14, 2019

Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.

Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 08, 2019

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.

Journal: Journal of Crohn's & colitis
Published: June 04, 2019

Corrigendum: Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.

Corrigendum: Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.

Journal: Inflammatory bowel diseases
Published: April 09, 2019

Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data.

Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data.

Journal: Journal of Crohn's & colitis
Published: March 09, 2019

No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System.

No Change in Determining Crohn's Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts' Scoring System.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 20, 2018

Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.

Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis.

Journal: Inflammatory bowel diseases
Published: September 19, 2018

Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.

Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.

Journal: Gastroenterology
Published: September 12, 2018

Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.

Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.

Journal: Journal of Crohn's & colitis
Published: August 12, 2018

Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.

Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.

Journal: Inflammatory bowel diseases
Published: July 13, 2018
Showing 1-12 of 163

Last Updated: 09/26/2026